Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)

 NMDE3_HUMAN             Reviewed;        1233 AA.
Q14957; B2RTT1;
01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
30-NOV-2010, sequence version 3.
31-JAN-2018, entry version 167.
RecName: Full=Glutamate receptor ionotropic, NMDA 2C;
Short=GluN2C;
AltName: Full=Glutamate [NMDA] receptor subunit epsilon-3;
AltName: Full=N-methyl D-aspartate receptor subtype 2C;
Short=NMDAR2C;
Short=NR2C;
Flags: Precursor;
Name=GRIN2C; Synonyms=NMDAR2C;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
TISSUE=Brain;
PubMed=9037519; DOI=10.1016/S0169-328X(96)00146-5;
Lin Y.J., Bovetto S., Carver J.M., Giordano T.;
"Cloning of the cDNA for the human NMDA receptor NR2C subunit and its
expression in the central nervous system and periphery.";
Brain Res. Mol. Brain Res. 43:57-64(1996).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16625196; DOI=10.1038/nature04689;
Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
"DNA sequence of human chromosome 17 and analysis of rearrangement in
the human lineage.";
Nature 440:1045-1049(2006).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
INTERACTION WITH SNX27.
PubMed=21300787; DOI=10.1128/MCB.01044-10;
Cai L., Loo L.S., Atlashkin V., Hanson B.J., Hong W.;
"Deficiency of sorting nexin 27 (SNX27) leads to growth retardation
and elevated levels of N-methyl-D-aspartate receptor 2C (NR2C).";
Mol. Cell. Biol. 31:1734-1747(2011).
[5]
FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
PubMed=26875626; DOI=10.1016/j.neuron.2016.01.016;
Hackos D.H., Lupardus P.J., Grand T., Chen Y., Wang T.M., Reynen P.,
Gustafson A., Wallweber H.J., Volgraf M., Sellers B.D., Schwarz J.B.,
Paoletti P., Sheng M., Zhou Q., Hanson J.E.;
"Positive Allosteric Modulators of GluN2A-Containing NMDARs with
Distinct Modes of Action and Impacts on Circuit Function.";
Neuron 89:983-999(2016).
[6]
FUNCTION, AND MUTAGENESIS OF PRO-550.
PubMed=28095420; DOI=10.1371/journal.pgen.1006536;
Ogden K.K., Chen W., Swanger S.A., McDaniel M.J., Fan L.Z., Hu C.,
Tankovic A., Kusumoto H., Kosobucki G.J., Schulien A.J., Su Z.,
Pecha J., Bhattacharya S., Petrovski S., Cohen A.E., Aizenman E.,
Traynelis S.F., Yuan H.;
"Molecular mechanism of disease-associated mutations in the pre-M1
helix of NMDA receptors and potential rescue pharmacology.";
PLoS Genet. 13:E1006536-E1006536(2017).
[7]
VARIANTS 18-TRP--VAL-1233 DEL; ILE-90; VAL-166; THR-573; THR-641;
CYS-679; THR-863; ARG-871; SER-877; ILE-911; ALA-982; PRO-989;
LEU-995; TYR-1079; ALA-1141; ARG-1180 AND ILE-1196.
PubMed=22833210; DOI=10.1038/tp.2011.52;
S2D team;
Tarabeux J., Kebir O., Gauthier J., Hamdan F.F., Xiong L., Piton A.,
Spiegelman D., Henrion E., Millet B., Fathalli F., Joober R.,
Rapoport J.L., DeLisi L.E., Fombonne E., Mottron L., Forget-Dubois N.,
Boivin M., Michaud J.L., Drapeau P., Lafreniere R.G., Rouleau G.A.,
Krebs M.O.;
"Rare mutations in N-methyl-D-aspartate glutamate receptors in autism
spectrum disorders and schizophrenia.";
Transl. Psychiatry 1:E55-E55(2011).
-!- FUNCTION: Component of NMDA receptor complexes that function as
heterotetrameric, ligand-gated ion channels with high calcium
permeability and voltage-dependent sensitivity to magnesium.
Channel activation requires binding of the neurotransmitter
glutamate to the epsilon subunit, glycine binding to the zeta
subunit, plus membrane depolarization to eliminate channel
inhibition by Mg(2+) (PubMed:26875626). Sensitivity to glutamate
and channel kinetics depend on the subunit composition (Probable).
Plays a role in regulating the balance between excitatory and
inhibitory activity of pyramidal neurons in the prefrontal cortex.
Contributes to the slow phase of excitatory postsynaptic current,
long-term synaptic potentiation, and learning (By similarity).
{ECO:0000250|UniProtKB:Q01098, ECO:0000269|PubMed:26875626,
ECO:0000269|PubMed:28095420, ECO:0000305}.
-!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:26875626). In vivo,
the subunit composition may depend on the expression levels of the
different subunits (Probable). Interacts with PDZ domains of PATJ
and DLG4 (By similarity). Interacts (via PDZ-binding motif) with
SNX27 (via PDZ domain); the interaction is required for recycling
to the plasma membrane when endocytosed and prevent degradation in
lysosomes (PubMed:21300787). {ECO:0000250|UniProtKB:Q00961,
ECO:0000269|PubMed:21300787, ECO:0000269|PubMed:26875626,
ECO:0000305}.
-!- INTERACTION:
Q62936:Dlg3 (xeno); NbExp=6; IntAct=EBI-8285963, EBI-349596;
P78352:DLG4; NbExp=4; IntAct=EBI-8285963, EBI-80389;
P31016:Dlg4 (xeno); NbExp=2; IntAct=EBI-8285963, EBI-375655;
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26875626};
Multi-pass membrane protein {ECO:0000305}. Cell junction, synapse,
postsynaptic cell membrane; Multi-pass membrane protein.
-!- TISSUE SPECIFICITY: Mainly expressed in brain with predominant
expression is in the cerebellum, also present in the hippocampus,
amygdala, caudate nucleus, corpus callosum, subthalamic nuclei and
thalamus. Detected in the heart, skeletal muscle and pancreas.
{ECO:0000269|PubMed:9037519}.
-!- DOMAIN: A hydrophobic region that gives rise to the prediction of
a transmembrane span does not cross the membrane, but is part of a
discontinuously helical region that dips into the membrane and is
probably part of the pore and of the selectivity filter.
{ECO:0000250|UniProtKB:Q00960}.
-!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
1.A.10.1) family. NR2C/GRIN2C subfamily. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; L76224; AAA88096.1; -; mRNA.
EMBL; AC068874; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC140801; AAI40802.1; -; mRNA.
CCDS; CCDS32724.1; -.
RefSeq; NP_000826.2; NM_000835.4.
UniGene; Hs.436980; -.
ProteinModelPortal; Q14957; -.
BioGrid; 109162; 3.
IntAct; Q14957; 3.
MINT; MINT-1776011; -.
STRING; 9606.ENSP00000293190; -.
BindingDB; Q14957; -.
ChEMBL; CHEMBL4109; -.
DrugBank; DB00659; Acamprosate.
DrugBank; DB00289; Atomoxetine.
DrugBank; DB00996; Gabapentin.
DrugBank; DB06741; Gavestinel.
DrugBank; DB00145; Glycine.
DrugBank; DB06738; Ketobemidone.
DrugBank; DB00142; L-Glutamic Acid.
DrugBank; DB04896; Milnacipran.
DrugBank; DB00312; Pentobarbital.
DrugBank; DB00454; Pethidine.
DrugBank; DB01174; Phenobarbital.
DrugBank; DB01708; Prasterone.
DrugBank; DB00418; Secobarbital.
DrugBank; DB01520; Tenocyclidine.
GuidetoPHARMACOLOGY; 458; -.
TCDB; 1.A.10.1.3; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
iPTMnet; Q14957; -.
PhosphoSitePlus; Q14957; -.
DMDM; 313104210; -.
PaxDb; Q14957; -.
PeptideAtlas; Q14957; -.
PRIDE; Q14957; -.
Ensembl; ENST00000293190; ENSP00000293190; ENSG00000161509.
GeneID; 2905; -.
KEGG; hsa:2905; -.
UCSC; uc002jlt.3; human.
CTD; 2905; -.
DisGeNET; 2905; -.
EuPathDB; HostDB:ENSG00000161509.13; -.
GeneCards; GRIN2C; -.
H-InvDB; HIX0039170; -.
HGNC; HGNC:4587; GRIN2C.
MIM; 138254; gene.
neXtProt; NX_Q14957; -.
OpenTargets; ENSG00000161509; -.
PharmGKB; PA28981; -.
eggNOG; KOG1053; Eukaryota.
eggNOG; ENOG410XNUR; LUCA.
GeneTree; ENSGT00760000119186; -.
HOVERGEN; HBG052636; -.
InParanoid; Q14957; -.
KO; K05211; -.
OMA; SAILYMM; -.
OrthoDB; EOG091G09KH; -.
PhylomeDB; Q14957; -.
TreeFam; TF314731; -.
Reactome; R-HSA-438066; Unblocking of NMDA receptor, glutamate binding and activation.
Reactome; R-HSA-442729; CREB phosphorylation through the activation of CaMKII.
Reactome; R-HSA-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
Reactome; R-HSA-6794361; Neurexins and neuroligins.
Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
SignaLink; Q14957; -.
GeneWiki; GRIN2C; -.
GenomeRNAi; 2905; -.
PRO; PR:Q14957; -.
Proteomes; UP000005640; Chromosome 17.
Bgee; ENSG00000161509; -.
CleanEx; HS_GRIN2C; -.
ExpressionAtlas; Q14957; baseline and differential.
Genevisible; Q14957; HS.
GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
GO; GO:0005622; C:intracellular; IEA:GOC.
GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
GO; GO:0005886; C:plasma membrane; TAS:Reactome.
GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
GO; GO:0005234; F:extracellularly glutamate-gated ion channel activity; IEA:InterPro.
GO; GO:0022849; F:glutamate-gated calcium ion channel activity; IDA:UniProtKB.
GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IDA:UniProtKB.
GO; GO:0033058; P:directional locomotion; IEA:Ensembl.
GO; GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc.
GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
GO; GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl.
GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
GO; GO:0008104; P:protein localization; IEA:Ensembl.
GO; GO:0009611; P:response to wounding; IEA:Ensembl.
GO; GO:0006810; P:transport; TAS:ProtInc.
InterPro; IPR001828; ANF_lig-bd_rcpt.
InterPro; IPR019594; Glu/Gly-bd.
InterPro; IPR001508; Iono_rcpt_met.
InterPro; IPR001320; Iontro_rcpt.
InterPro; IPR018884; NMDAR2_C.
InterPro; IPR028082; Peripla_BP_I.
Pfam; PF01094; ANF_receptor; 1.
Pfam; PF00060; Lig_chan; 1.
Pfam; PF10613; Lig_chan-Glu_bd; 1.
Pfam; PF10565; NMDAR2_C; 1.
PRINTS; PR00177; NMDARECEPTOR.
SMART; SM00918; Lig_chan-Glu_bd; 1.
SMART; SM00079; PBPe; 1.
SUPFAM; SSF53822; SSF53822; 1.
1: Evidence at protein level;
Calcium; Cell junction; Cell membrane; Complete proteome;
Disulfide bond; Glycoprotein; Ion channel; Ion transport;
Ligand-gated ion channel; Magnesium; Membrane; Phosphoprotein;
Polymorphism; Postsynaptic cell membrane; Receptor;
Reference proteome; Signal; Synapse; Transmembrane;
Transmembrane helix; Transport.
SIGNAL 1 19 {ECO:0000255}.
CHAIN 20 1233 Glutamate receptor ionotropic, NMDA 2C.
/FTId=PRO_0000011580.
TOPO_DOM 20 554 Extracellular.
{ECO:0000250|UniProtKB:Q00960}.
TRANSMEM 555 573 Helical. {ECO:0000250|UniProtKB:Q00960}.
TOPO_DOM 574 600 Cytoplasmic.
{ECO:0000250|UniProtKB:Q00960}.
INTRAMEM 601 620 Discontinuously helical.
{ECO:0000250|UniProtKB:Q00960}.
TOPO_DOM 621 627 Cytoplasmic.
{ECO:0000250|UniProtKB:Q00960}.
TRANSMEM 628 643 Helical. {ECO:0000250|UniProtKB:Q00960}.
TOPO_DOM 644 814 Extracellular.
{ECO:0000250|UniProtKB:Q00960}.
TRANSMEM 815 834 Helical. {ECO:0000250|UniProtKB:Q00960}.
TOPO_DOM 835 1233 Cytoplasmic.
{ECO:0000250|UniProtKB:Q00960}.
REGION 509 511 Glutamate binding.
{ECO:0000250|UniProtKB:Q00959}.
REGION 601 620 Pore-forming.
{ECO:0000250|UniProtKB:Q00960}.
REGION 687 688 Glutamate binding.
{ECO:0000250|UniProtKB:Q00959}.
MOTIF 1231 1233 PDZ-binding.
BINDING 511 511 Glutamate.
{ECO:0000250|UniProtKB:Q00960}.
BINDING 516 516 Glutamate.
{ECO:0000250|UniProtKB:Q00959}.
BINDING 729 729 Glutamate.
{ECO:0000250|UniProtKB:Q00960}.
SITE 612 612 Functional determinant of NMDA receptors.
{ECO:0000250}.
MOD_RES 875 875 Phosphoserine.
{ECO:0000250|UniProtKB:Q01098}.
MOD_RES 881 881 Phosphoserine.
{ECO:0000250|UniProtKB:Q01098}.
MOD_RES 912 912 Phosphoserine.
{ECO:0000250|UniProtKB:Q00961}.
CARBOHYD 70 70 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 337 337 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 438 438 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 539 539 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 82 317 {ECO:0000250|UniProtKB:Q00959}.
DISULFID 426 453 {ECO:0000250|UniProtKB:Q00959}.
DISULFID 433 454 {ECO:0000250|UniProtKB:Q00959}.
DISULFID 743 798 {ECO:0000250|UniProtKB:Q00959}.
VARIANT 18 1233 Missing (found in a patient with autism
spectrum disorder; unknown pathological
significance).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079958.
VARIANT 90 90 V -> I (in dbSNP:rs192960268).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079959.
VARIANT 166 166 A -> V (in dbSNP:rs201199917).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079960.
VARIANT 573 573 M -> T. {ECO:0000269|PubMed:22833210}.
/FTId=VAR_079961.
VARIANT 641 641 A -> T (in dbSNP:rs746610735).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079962.
VARIANT 679 679 R -> C (found in a patient with
schizophrenia; unknown pathological
significance).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079963.
VARIANT 863 863 I -> T (found in a patient with autism
spectrum disorder; unknown pathological
significance).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079964.
VARIANT 871 871 Q -> R (in dbSNP:rs765016248).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079965.
VARIANT 877 877 P -> S (in dbSNP:rs139011774).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079966.
VARIANT 911 911 S -> I (in dbSNP:rs370546831).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079967.
VARIANT 982 982 P -> A (in dbSNP:rs960726960).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079968.
VARIANT 989 989 S -> P (found in a patient with
schizophrenia; unknown pathological
significance; dbSNP:rs552196496).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079969.
VARIANT 995 995 S -> L (found in a patient with
schizophrenia; unknown pathological
significance).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079970.
VARIANT 1079 1079 H -> Y (in dbSNP:rs889196426).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079971.
VARIANT 1141 1141 P -> A (in dbSNP:rs751640851).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079972.
VARIANT 1180 1180 G -> R (in dbSNP:rs115230539).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079973.
VARIANT 1196 1196 T -> I (in dbSNP:rs143282101).
{ECO:0000269|PubMed:22833210}.
/FTId=VAR_079974.
VARIANT 1209 1209 R -> S (in dbSNP:rs3744215).
/FTId=VAR_037634.
MUTAGEN 550 550 P->R: Changed glutamate-gated calcium ion
channel activity characterized by
increased glutamate and glycine potency.
{ECO:0000269|PubMed:28095420}.
CONFLICT 1048 1048 E -> EPPE (in Ref. 3; AAI40802).
{ECO:0000305}.
CONFLICT 1057 1057 P -> K (in Ref. 1; AAA88096).
{ECO:0000305}.
SEQUENCE 1233 AA; 134209 MW; 7B1F2F7995C0D689 CRC64;
MGGALGPALL LTSLFGAWAG LGPGQGEQGM TVAVVFSSSG PPQAQFRARL TPQSFLDLPL
EIQPLTVGVN TTNPSSLLTQ ICGLLGAAHV HGIVFEDNVD TEAVAQILDF ISSQTHVPIL
SISGGSAVVL TPKEPGSAFL QLGVSLEQQL QVLFKVLEEY DWSAFAVITS LHPGHALFLE
GVRAVADASH VSWRLLDVVT LELGPGGPRA RTQRLLRQLD APVFVAYCSR EEAEVLFAEA
AQAGLVGPGH VWLVPNLALG STDAPPATFP VGLISVVTES WRLSLRQKVR DGVAILALGA
HSYWRQHGTL PAPAGDCRVH PGPVSPAREA FYRHLLNVTW EGRDFSFSPG GYLVQPTMVV
IALNRHRLWE MVGRWEHGVL YMKYPVWPRY SASLQPVVDS RHLTVATLEE RPFVIVESPD
PGTGGCVPNT VPCRRQSNHT FSSGDVAPYT KLCCKGFCID ILKKLARVVK FSYDLYLVTN
GKHGKRVRGV WNGMIGEVYY KRADMAIGSL TINEERSEIV DFSVPFVETG ISVMVARSNG
TVSPSAFLEP YSPAVWVMMF VMCLTVVAIT VFMFEYFSPV SYNQNLTRGK KSGGPAFTIG
KSVWLLWALV FNNSVPIENP RGTTSKIMVL VWAFFAVIFL ASYTANLAAF MIQEQYIDTV
SGLSDKKFQR PQDQYPPFRF GTVPNGSTER NIRSNYRDMH THMVKFNQRS VEDALTSLKM
GKLDAFIYDA AVLNYMAGKD EGCKLVTIGS GKVFATTGYG IAMQKDSHWK RAIDLALLQF
LGDGETQKLE TVWLSGICQN EKNEVMSSKL DIDNMAGVFY MLLVAMGLAL LVFAWEHLVY
WKLRHSVPNS SQLDFLLAFS RGIYSCFSGV QSLASPPRQA SPDLTASSAQ ASVLKMLQAA
RDMVTTAGVS SSLDRATRTI ENWGGGRRAP PPSPCPTPRS GPSPCLPTPD PPPEPSPTGW
GPPDGGRAAL VRRAPQPPGR PPTPGPPLSD VSRVSRRPAW EARWPVRTGH CGRHLSASER
PLSPARCHYS SFPRADRSGR PFLPLFPELE DLPLLGPEQL ARREALLHAA WARGSRPRHA
SLPSSVAEAF ARPSSLPAGC TGPACARPDG HSACRRLAQA QSMCLPIYRE ACQEGEQAGA
PAWQHRQHVC LHAHAHLPFC WGAVCPHLPP CASHGSWLSG AWGPLGHRGR TLGLGTGYRD
SGGLDEISRV ARGTQGFPGP CTWRRISSLE SEV


Related products :

Catalog number Product name Quantity
EIAAB27383 Glutamate [NMDA] receptor subunit epsilon-3,GRIN2C,Homo sapiens,Human,NMDAR2C,NMDAR2C,N-methyl D-aspartate receptor subtype 2C,NR2C
18-003-42615 Glutamate [NMDA] receptor subunit epsilon 3 - N-methyl D-aspartate receptor subtype 2C; NR2C; NMDAR2C Polyclonal 0.05 mg Aff Pur
EIAAB27381 Glutamate [NMDA] receptor subunit epsilon-3,Grin2c,NMDAR2C,N-methyl D-aspartate receptor subtype 2C,NR2C,Rat,Rattus norvegicus
EIAAB27382 Glutamate [NMDA] receptor subunit epsilon-3,Grin2c,Mouse,Mus musculus,NMDAR2C,N-methyl D-aspartate receptor subtype 2C,NR2C
EIAAB27378 Glutamate [NMDA] receptor subunit epsilon-2,GRIN2B,hNR3,Homo sapiens,Human,NMDAR2B,NMDAR2B,N-methyl D-aspartate receptor subtype 2B,N-methyl-D-aspartate receptor subunit 3,NR2B,NR3
EIAAB27370 Glutamate [NMDA] receptor subunit 3A,Glutamate receptor chi-1,Grin3a,NMDAR3A,NMDAR-L,NMDAR-L1,N-methyl-D-aspartate receptor,N-methyl-D-aspartate receptor subtype 3A,NR3A,Rat,Rattus norvegicus
EIAAB27374 Glutamate [NMDA] receptor subunit epsilon-1,Grin2a,NMDAR2A,N-methyl D-aspartate receptor subtype 2A,NR2A,Rat,Rattus norvegicus
EIAAB27384 Glutamate [NMDA] receptor subunit epsilon-4,Grin2d,Mouse,Mus musculus,NMDAR2D,N-methyl D-aspartate receptor subtype 2D,NR2D
EIAAB27379 Glutamate [NMDA] receptor subunit epsilon-2,Grin2b,NMDAR2B,N-methyl D-aspartate receptor subtype 2B,NR2B,Rat,Rattus norvegicus
EIAAB27380 Glutamate [NMDA] receptor subunit epsilon-2,Grin2b,Mouse,Mus musculus,NMDAR2B,N-methyl D-aspartate receptor subtype 2B,NR2B
EIAAB27386 Glutamate [NMDA] receptor subunit epsilon-4,Grin2d,NMDAR2D,N-methyl D-aspartate receptor subtype 2D,NR2D,Rat,Rattus norvegicus
EIAAB27376 Glutamate [NMDA] receptor subunit epsilon-1,Grin2a,Mouse,Mus musculus,NMDAR2A,N-methyl D-aspartate receptor subtype 2A,NR2A
EIAAB27375 Glutamate [NMDA] receptor subunit epsilon-1,GRIN2A,hNR2A,Homo sapiens,Human,NMDAR2A,NMDAR2A,N-methyl D-aspartate receptor subtype 2A,NR2A
EIAAB27385 EB11,Glutamate [NMDA] receptor subunit epsilon-4,GRIN2D,Homo sapiens,Human,NMDAR2D,NMDAR2D,N-methyl D-aspartate receptor subtype 2D,NR2D
18-662-20015 Glutamate - N-methyl D-aspartate receptor subtype 2C; NR2C; NMDAR2C Polyclonal 0.01 mg
EIAAB27372 Glutamate [NMDA] receptor subunit 3B,Grin3b,NMDAR3B,N-methyl-D-aspartate receptor subtype 3B,NR3B,Rat,Rattus norvegicus
EIAAB27371 Glutamate [NMDA] receptor subunit 3B,GRIN3B,Homo sapiens,Human,NMDAR3B,N-methyl-D-aspartate receptor subtype 3B,NR3B
EIAAB27377 Canis familiaris,Canis lupus familiaris,Dog,Glutamate [NMDA] receptor subunit epsilon-2,GRIN2B,NMDAR2B,N-methyl D-aspartate receptor subtype 2B,NR2B
EIAAB27369 Glutamate [NMDA] receptor subunit 3A,GRIN3A,Homo sapiens,Human,KIAA1973,NMDAR3A,NMDAR-L,N-methyl-D-aspartate receptor subtype 3A,NR3A
EIAAB27373 Glutamate [NMDA] receptor subunit 3B,Grin3b,Mouse,Mus musculus,NMDA receptor 4,NMDAR3B,N-methyl-D-aspartate receptor subunit NR3B,NR3B,Nr4
EIAAB27389 Glutamate [NMDA] receptor subunit zeta-1,Grin1,Nmdar1,NMD-R1,N-methyl-D-aspartate receptor subunit NR1,Rat,Rattus norvegicus
EIAAB27388 Glurz1,Glutamate [NMDA] receptor subunit zeta-1,Grin1,Mouse,Mus musculus,NMD-R1,N-methyl-D-aspartate receptor subunit NR1
EIAAB27390 Glutamate [NMDA] receptor subunit zeta-1,GRIN1,Homo sapiens,Human,NMDAR1,NMD-R1,N-methyl-D-aspartate receptor subunit NR1
18-373-88024 Glutamate [NMDA] receptor subunit zeta 1 - N-methyl-D-aspartate receptor subunit NR1 Polyclonal 0.5 ml
18-373-88008 Glutamate [NMDA] receptor subunit zeta 1 - N-methyl-D-aspartate receptor subunit NR1 Polyclonal 0.5 ml


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur